ALNITAK PHARMACEUTICALS

village jagaat khana, Nalagarh, 

Himachal Pradesh 174101

 

 
PACK SIZE AS PER SCHEDULE P-1 THE DRUG & COSMETICS RULES 1945
Sr. No. Dosage Form Generic Name Composition Spc. Qty. Unit Marketed By Approved or Rejected

 

01. Tablets  Levofloxacin Tablets I.P. Each film coated tablet contains: Self Approved -05.08.15
Levofloxacin hemihydrate

eq. to Levofloxacin

I.P. 500 mg
Excipients q.s.
Approved colour used
02. Tablets Levofloxacin  Tablets I.P. Each film coated tablet contains: Self Approved -05.08.15
Levofloxacin hemihydrate

eq.to Levofloxacin

I.P. 750 mg
Excipients q.s.
Approved Colour used
03. Tablets Ferrous Ascorbate,Folic acid and Zinc Sulphate Monohydrate Tablets Each Film coated tablet contains: Self Approved -05.08.15
Ferrous ascorbate

eq. to elemental iron

100 mg
Folic Acid I.P. 1.5 mg
Zinc Sulphate Monohydrate

eq. to elemental zinc

I.P. 22.5 mg
Excipients q.s.
Approved colour used
04. Tablets Ofloxacin and Ornidazole Tablets Each film coated tablet contains: Self Approved -05.08.15
Ofloxacin I.P. 200 mg
Ornidazole I.P. 500 mg
Excipients q.s.
Approved Colour used
05. Tablets Rabeprazole Gastro-resistant Tablets I.P. Each enteric coated tablet contains: Self Approved -05.08.15
Rabeprazole Sodium I.P. 20 mg
Excipients q.s.
Approved colour used
06. Tablets Deflazacort Tablets Each uncoated tablet contains: Self Approved -05.08.15
Deflazacort 6 mg
Excipients q.s.
Approved colour used
07. Tablets Deflazacort Tablets Each uncoated tablet contains: Self  

Approved -05.08.15

Deflazacort 30 mg
Excipients q.s.
Approved colour used
08. Tablets Azithromycin Tablets I.P.

 

Each film coated tablet contains : Self Approved -05.08.15
Azithromycin Dihydrate

eq.to Azithromycin anhydrous

I.P. 250 mg
Excipients q.s.
Approved colour used
09. Tablets Azithromycin Tablets I.P.

 

Each film coated tablet contains : Self Approved -05.08.15
Azithromycin Dihydrate

eq.to Azithromycin anhydrous

I.P. 500 mg
Excipients q.s.
Approved colour used
10. Liquid Orals Albendazole Oral Suspension I.P. Each 5ml contains: Self Approved -05.08.15
Albendazole I.P. 200 mg
Excipients q.s.
In a flavoured base q.s.
Approved Colour used

 

11. Liquid Orals Magaldrate and Simethicone Oral Suspension U.S.P. Each 5ml contains: Self Approved -05.08.15

 

 

 

 

 

 

 

 

 

 

Magaldrate (Anhydrous) I.P. 400 mg
Simethicone I.P. 60 mg
In a palatable suspension base
Excipients q.s.
Approved Colour used
12. Liquid Orals Ferrous Ascorbate and Folic Acid Suspension Each 5ml contains: Self  Approved -05.08.15
Ferrous Ascorbate

eq.to elemental iron

I.P. 30 mg
Folic Acid I.P. 550 mcg
Excipients q.s.
Flavoured syrupy base q.s.
Colour: Approved colour used
13. Liquid Orals Terbutaline Sulphate,Ambroxol hydrochloride, Guaiphenesin and Menthol Syrup Each 5ml contains: Self Approved -05.08.15
Terbutaline Sulphate I.P. 1.25 mg
Ambroxol hydrochloride I.P. 15 mg
Guaiphenesin I.P. 50 mg
Menthol I.P. 2.5 mg
Excipients q.s.
Flavoured syrupy base q.s.
Colour: Approved colour used
14. Liquid Orals Dried Aluminium Hydroxide Gel,Magnesium Hydroxide and Activated Dimethicone Suspension Each 5ml contains: Self Approved -05.08.15
Dried Aluminium Hydroxide Gel

eq.to Aluminium Hydroxide

I.P. 250 mg
Magnesium Hydroxide I.P. 250 mg
Activated Dimethicone I.P. 50 mg
Flavoured Sorbitol Solution (70%) {Non-Crystallizing} I.P. 1.25 gm
Purified Water I.P. q.s.
Excipients q.s.
Colour: Approved colour used
15. Capsules Omeprazole Gastro-resistant Capsules I.P. Each hard gelatin capsule contains: Self Approved -05.08.15
Omeprazole (as enteric coated granules) I.P. 20 mg
Excipients q.s.
Approved colour used in capsule shells
16. Capsules Omeprazole and Domperidone Capsules Each hard gelatin capsule contains: Self Approved -05.08.15
Omeprazole (as enteric coated granules) I.P. 20 mg
Domepridone I.P. 10 mg
Excipients q.s.
Approved colour used in capsule shells
17. Capsules Rabeprazole and Domperidone Capsules Each hard gelatin capsule contains: Self Approved -05.08.15
Rabeprazole Sodium

(as enteric coated pellets)

I.P. 20 mg
Domepridone

(as sustained released pellets)

I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
18. Capsules Pantoprazole and Domperidone Capsules Each hard gelatin capsule contains: Self Approved -05.08.15
Pantoprazole Sodium

eq.to Pantoprazole

(as enteric coated pellets)

I.P.  

40

 

mg

Domepridone

(as sustained released pellets)

I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
19. Capsules Fluconazole Capsules I.P. Each hard gelatin capsule contains: Self Approved -05.08.15
Fluconazole I.P. 150 mg
Excipients q.s.
Approved colour used in capsule shells
20. Capsules Pantoprazole and Itopride Hydrochloride Capsules Each hard gelatin capsule contains: Self Approved -05.08.15
Pantoprazole Sodium

eq.to Pantoprazole

(as enteric coated pellets)

I.P.  

40

 

mg

Itopride Hydrochloride

(as sustained released pellets)

150 mg
Excipients q.s.
Approved colour used in empty capsule shells
21. Capsules Rabeprazole and Levosulpride Capsules Each hard gelatin capsule contains: Self  Approved -05.08.15
Rabeprazole Sodium

(as enteric coated pellets)

I.P. 20 mg
Levosulpride

(as sustained released pellets)

75 mg
Excipients q.s.
Approved colour used in empty capsule shells
22. Tablets Roxithromycin Tablets I.P. Each film coated tablet contains : Self Approved -20.08.15
Roxithromycin I.P. 150 mg
Excipients q.s.
Approved colour used
23. Tablets Montelukast and Levocetirizine Tablets Each film coated tablet contains : Self Approved -20.08.15
Montelukast Sodium

eq.to Montelukast

I.P.  

10

 

mg

Levocetirizine hydrochloride I.P. 5 mg
Excipients q.s.
Approved colour used
24. Tablets Paracetamol and Nimesulide  Tablets

(Not to be used for children below 12 years of age)

 

 

Each uncoated tablet contains : Self Approved -20.08.15
Paracetamol I.P. 325 mg
Nimesulide B.P. 100 mg
Excipients q.s.
Approved colour used
25. Tablets Pantoprazole and Domperidone Tablets Each enteric coated tablet contains: Self Approved -20.08.15
Pantoprazole Sodium

eq.to Pantoprazole

I.P.  

40

 

mg

Domperidone I.P. 10 mg
Excipients q.s.
Approved colour used
26. Tablets Ondansetron Orally

Disintegrating

Tablets I.P.

Each uncoated tablet contains: Self Approved -20.08.15
Ondansetron hydrochloride

eq. to Ondansetron

I.P. 4 mg
Excipients q.s.
Approved colour used

 

27.

 

Tablets Diclofenac Sodium and  Paracetamol Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each uncoated tablet contains : Self Approved -20.08.15
Diclofenac Sodium I.P. 50 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved colour used
28. Tablets Lornoxicam and Paracetamol Tablets Each film coated tablet contains: Self Approved -20.08.15
Lornoxicam 8 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
29. Tablets Etoricoxib Tablets I.P. Each film coated tablet contains: Self Approved -20.08.15
Etoricoxib I.P. 90 mg
Excipients q.s.
Approved Colour used
30. Tablets Etoricoxib Tablets I.P. Each film coated tablet contains: Self Approved -20.08.15
Etoricoxib I.P. 120 mg
Excipients q.s.
Approved Colour used
31. Tablets Etoricoxib and  Thiocolchicoside Tablets Each film coated tablet contains: Self  Approved -20.08.15
Etoricoxib I.P. 60 mg
Thiocolchicoside I.P. 4 mg
Excipients
Approved Colour used
32. Tablets Desloratadine and  Montelukast Tablets Each film coated tablet contains: Self Approved -20.08.15
Desloratadine 5 mg
Montelukast Sodium

eq. to Montelukast

I.P.  

10

 

mg

Excipients
Approved Colour used
33. Tablets Aceclofenac and Paracetamol   Tablets Each uncoated tablet contains: Self Approved -20.08.15
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved colour used
34. Tablets Ofloxacin Tablets I.P. Each film coated tablet contains: Self Approved -20.08.15
Ofloxacin I.P. 200 mg
Excipients q.s.
Approved colour used

 

 

 

 

 

35. Tablets Pantoprazole Gastro-resistant   Tablets I.P. Each enteric-coated tablet contains: Self Approved -20.08.15
Pantoprazole Sodium

eq.to Pantoprazole

I.P. 40 mg
Excipients q.s.
Approved Colour used
36. Tablets Ciprofloxacin Tablets I.P. Each film coated tablet contains: Self Approved -20.08.15
Ciprofloxacin Hydrochloride

eq.to Ciprofloxacin

I.P. 250 mg
Excipients q.s.
Approved colour used
37. Tablets Ciprofloxacin Tablets I.P. Each film coated tablet contains: Self Approved -20.08.15
Ciprofloxacin Hydrochloride

eq.to Ciprofloxacin

I.P. 500 mg
Excipients q.s.
Approved colour used
38. Tablets Albendazole Tablets I.P. Each uncoated chewable tablet contains: Self Approved -20.08.15
Albendazole I.P. 400 mg
Excipients q.s.
Approved Colour used
39. Tablets Levocetirizine Dihydrochloride Tablets I.P. Each uncoated tablet contains: Self Approved -20.08.15
Levocetirizine Dihydrochloride I.P. 5 mg
Excipients q.s.
Approved colour used
40.

 

Tablets Fexofenadine and Montelukast Tablets Each chewable film coated tablet contains : Self Approved -03.09.15
Fexofenadine Hydrochloride I.P. 120 mg
Montelukast Sodium

eq.to Montelukast

I.P.  

10

 

mg

Excipients q.s.
Approved colour used
41. Tablets Aceclofenac Sustained Released Tablets 200mg Each uncoated sustained released tablet contains : Self Approved -03.09.15
Aceclofenac I.P. 200 mg
Excipients q.s.
Approved colour used
42. Liquid Orals Paracetamol Paediatric Oral Suspension I.P. Each 5ml contains : Self Approved -03.09.15
Paracetamol I.P. 125 mg
Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
43. Liquid Orals Paracetamol Paediatric Oral Suspension I.P. Each 5ml contains : Self Approved -03.09.15
Paracetamol I.P. 250 mg
Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
44. Liquid Orals Ondansetron Oral Solution I.P. Each 5ml contains : Self Approved -03.09.15
Ondansetron Hydrochloride

eq.to Ondansetron

I.P.  

2

 

mg

Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
45. Tablets Fluconazole Tablets I.P. Each uncoated tablet contains : Self Approved -03.09.15
Fluconazole I.P. 150 mg
Excipients q.s.
Approved colour used
46. Tablets Fluconazole Tablets I.P. Each uncoated tablet contains : Self Approved -03.09.15
Fluconazole I.P. 200 mg
Excipients q.s.
Approved colour used
47. Tablets Levofloxacin Tablets I.P. Each film coated tablet contains : Self Approved -03.09.15
Levofloxacin Hemihydrate

eq.to Levofloxacin

I.P.  

250

 

mg

Excipients q.s.
Approved colour used
48. Tablets Ondansetron Orally Disintegrating Tablets I.P. Each uncoated tablet contains : Self Approved -03.09.15
Ondansetron Hydrochloride

eq.to Ondansetron

I.P.  

8

 

mg

Excipients q.s.
Approved colour used
49. Tablets Cetirizine Hydrochloride Tablets I.P. Each uncoated tablet contains : Self Approved -03.09.15
Cetirizine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved colour used

 

 

 

50. Tablets Nimesulide Tablets Each uncoated tablet contains : Self Approved -03.09.15
Nimesulide B.P. 100 mg
Excipients q.s.
Approved colour used
51. Tablets Doxofylline Tablets I.P. Each uncoated tablet contains : Self Approved -03.09.15

 

Doxofylline I.P. 400 mg
Excipients q.s.
Approved colour used
52. Liquid Orals Ofloxacin Oral Suspension I.P. Each 5ml contains : Self Approved -03.09.15
Ofloxacin I.P. 50 mg
Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
53. Tablets Albendazole and Ivermectin Tablets Each uncoated tablet contains : Self Approved -03.09.15
Albendazole I.P. 400 mg
Ivermectin I.P. 6 mg
Excipients q.s.
Approved colour used
54. Tablets Levocetirizine Hydrochloride and Montelukast Tablets Each film coated tablet contains : Self Approved -03.09.15
Levocetirizine Hydrochloride I.P. 2.5 mg
Montelukast Sodium

eq.to Montelukast

I.P. 4  

mg

Excipients q.s.
Approved colour used
55. Tablets Ofloxacin and Nitazoxanide Tablets Each film coated tablet contains : Self Approved -03.09.15
Ofloxacin I.P. 200 mg
Nitazoxanide 500 mg
Excipients q.s.
Approved colour used
56. Capsules Omeprazole and Domperidone Capsules Each hard gelatin capsule contains : Self Approved -03.09.15
Omeprazole (as enteric coated granules) I.P. 20 mg
Domperidone (as sustained released pellets) I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
57. Capsules Esomeprazole and Domperidone Capsules Each hard gelatin capsule contains : Self Approved -03.09.15
Esomeprazole  Magnesium Trihydrate

eq. to Esomeprazole (as enteric coated pellets)

I.P.  

20

 

mg

Domperidone (as sustained released pellets) I.P. 30 mg
Excipients q.s.
Approved colour used in empty capsule shells
58. Liquid Orals Azithromycin Oral Suspension I.P. Each 5ml contains : Self Approved -03.09.15
Azithromycin  Dihydrate

eq.to anhydrous Azithromycin

I.P.  

200

 

mg

Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
59.

 

Liquid Orals Phenylephrine HCl,Paracetamol, Chlorpheniramine Maleate,Sodium Citrate and Menthol Syrup Each 5ml contains : Self Approved -03.09.15
Phenylephrine HCl I.P. 5 mg
Paracetamol I.P. 125 mg
Chlorpheniramine Maleate I.P. 0.5 mg
Sodium Citrate I.P. 60 mg
Menthol I.P. 1 mg
Excipients
Flavoured syrupy base q.s.
Approved colour used
60. Tablets Glucosamine,Methyl   sulphonylmethane and Diacerein Tablets Each film coated tablet contains : Self Approved -03.09.15
Glucosamine Sulphate Potassium Chloride

eq.to Glucosamine

USP 750

446

mg

mg

Methylsulphonylmethane USP 250 mg
Diacerein I.P. 50 mg
Excipients q.s.
Approved colour used
61. Tablets Ferrous Ascorbate and Folic Acid Tablets Each film coated tablet contains : Self Approved -03.09.15
Ferrous Ascorbate

eq.to elemental  iron

I.P.  

100

 

mg

Folic Acid I.P. 1.5 mg
Excipients q.s.
Approved colour used

 

62. Capsules Pregabalin and Methylcobalamin Capsules Each hard gelatin capsule contains : Self Approved -03.09.15
Pregabalin I.P. 75 mg
Methylcobalamin J.P. 750 mcg
Excipients q.s.
Approved colour used in empty capsule shells
Appropriate overages of vitamin added to compensate loss on storage.
63. Tablets Diclofenac Potassium and Serratiopeptidase Tablets Each enteric coated tablet contains : Self Approved -03.09.15
Diclofenac Potassium B.P. 50 mg
Serratiopeptidase

(as enteric coated granules

eq.to enzymatic activity 20,000 units)

I.P. 10 mg
Excipients q.s.
Approved Colour used
64. Tablets Fexofenadine Hydrochloride Tablets I.P. Each film coated tablet contains : Self Approved -24.12.15
Fexofenadine Hydrochloride I.P. 120 mg
Excipients q.s.
Approved colour used
65. Tablets Fexofenadine Hydrochloride Tablets I.P. Each film coated tablet contains : Self Approved -24.12.15
Fexofenadine Hydrochloride I.P. 180 mg
Excipients q.s.
Approved colour used
66. Tablets Atorvastatin Tablets I.P. Each film-coated tablet contains : Self Approved -24.12.15
Atorvastatin Calcium

eq.to Atorvastatin

I.P.  

10

 

mg

Excipients q.s.
Approved colour used
67. Tablets Atorvastatin Tablets I.P. Each film-coated tablet contains : Self Approved -24.12.15
Atorvastatin Calcium

eq.to Atorvastatin

I.P.  

20

 

mg

Excipients q.s.
Approved colour used
68. Tablets Atorvastatin Tablets I.P. Each film-coated tablet contains : Self Approved -24.12.15
Atorvastatin Calcium

eq.to Atorvastatin

I.P.  

40

 

mg

Excipients q.s.
Approved colour used
69. Tablets Atenolol Tablets I.P. Each uncoated tablet contains : Self Approved -24.12.15
Atenolol I.P. 50 mg
Excipients q.s.
Approved colour used
70. Tablets Atenolol Tablets I.P. Each uncoated tablet contains : Self Approved -24.12.15
Atenolol I.P. 100 mg
Excipients q.s.
Approved colour used
71. Tablets Glimepiride Tablets I.P. Each uncoated tablet contains : Self Approved -24.12.15
Glimepiride I.P. 2 mg
Excipients q.s.
Approved colour used
72. Tablets Sildenafil Citrate Tablets I.P. Each film-coated tablet contains : Self Approved -24.12.15
Sildenafil Citrate

eq.to Sildenafil

I.P.  

50

 

mg

Excipients q.s.
Approved colour used
73. Tablets Sildenafil Citrate Tablets I.P. Each film-coated tablet contains : Self Approved -24.12.15
Sildenafil Citrate

eq.to Sildenafil

I.P.  

100

 

mg

Excipients q.s.
Approved colour used
74. Tablets Telmisartan and Amlodipine Besilate Tablets Each uncoated tablet contains : Self Approved -24.12.15
Telmisartan I.P. 80 mg
Amlodipine Besilate

eq.to Amlodipine

I.P. 5 mg
Excipients q.s.
Approved colour used
75. Tablets Paracetamol and Tramadol Hydrochloride Tablets Each film-coated tablet contains : Self Approved -24.12.15
Paracetamol I.P. 325 mg
Tramadol Hydrochloride I.P. 37.5 mg
Excipients q.s.
Approved colour used

 

76. Tablets Montelukast and Levocetirizine Hydrochloride Tablets Each uncoated Dispersible tablet contains : Self Approved -24.12.15
Montelukast Sodium

eq.to Montelukast

I.P.  

5

 

mg

Levocetirizine Hydrochloride I.P. 2.5 mg
Excipients q.s.
Approved colour used
77. Liquid Orals Ambroxol HCl,Levosalbutamol Sulphate and Guaiphenesin Syrup Each 5ml contains : Self Approved -24.12.15
Ambroxol Hydrochloride I.P. 30 mg
Levosalbutamol Sulphate

eq.to Levosalbutamol

I.P. 1 mg
Guaiphenesin I.P. 50 mg
Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
78. Liquid Orals Levocetirizine Hydrochloride Syrup Each 5ml contains : Self Approved -24.12.15
Levocetirizine Hydrochloride I.P. 2.5 mg
Excipients q.s.
In a Flavoured syrupy base q.s.
Approved colour used
79. Liquid Orals Dried Aluminium Hydroxide,Magnesium Hydroxide,Simethicone and Oxetacaine Syrup Each 5ml contains : Self Approved -24.12.15
Dried Aluminium Hydroxide Gel

eq.to Aluminium Hydroxide

I.P.  

600

 

mg

Magnesium Hydroxide I.P. 300 mg
Simethicone I.P. 25 mg
Oxetacaine B.P. 10 mg
Purified Water I.P. q.s.
Excipients q.s.
Flavoured syrupy base q.s.
Approved colour used
80. Liquid Orals Deflazacort Oral Suspension Each 5ml contains: Self Approved -16.02.16
Deflazacort 6 mg
Flavoured Syrupy base q.s.
Excipients q.s.
Approved Colour used
81. Tablets Duloxetine Hydrochloride Tablets Each film coated tablet contains: Self Approved -16.02.16
Duloxetine Hydrochloride

eq.to Duloxetine

USP 20 mg
Excipients q.s.
Approved Colour used
82. Tablets Etoricoxib and Paracetamol Tablets Each film coated tablet contains: Self Approved -16.02.16
Etoricoxib I.P. 60 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
83. Tablets Betahistine Hydrochloride Tablets I.P. Each film coated tablet contains : Self Approved -16.02.16
Betahistine Hydrochloride I.P. 16 mg
Excipients q.s.
Approved Colour used
84. Tablets Tranexamic Acid and Mefenamic Acid Tablets Each film coated tablet contains : Self Approved -16.02.16
Tranexamic Acid I.P. 500 mg
Mefenamic Acid I.P. 250 mg
Excipients q.s.
Approved Colour used
85. Capsules Rebeprazole and Itopride Hydrochloride Capsules Each hard gelatin capsules contains : Self  Approved -16.02.16
Rebeprazole Sodium

(as enteric coated pellets)

I.P. 20 mg
Itopride Hydrochloride

(as sustained released pellets)

150 mg
Excipients q.s.
Approved Colour used
86. Tablets Artemether and Lumefantrine Tablets Each uncoated tablet contains : Self Approved -16.02.16
Artemether I.P. 80 mg
Lumefantrine 480 mg
Excipients q.s.
Approved Colour used
87. Tablets Lornoxicam and Paracetamol Tablets Each film coated tablet contains : Self  Approved -16.02.16
Lornoxicam 4 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used

 

 

 

88. Tablets Levocetirizine Hydrochloride and Ambroxol Hydrochloride (SR) Tablets Each uncoated sustained released tablet contains : Self Approved -16.02.16
Levocetirizine Hydrochloride I.P. 5 mg
Ambroxol Hydrochloride (as sustained released) I.P. 75 mg
Excipients q.s.
Approved Colour used
89. Tablets Aceclofenac and Thiocolchicoside Tablets Each film coated tablet contains : Self  Approved -16.02.16
Aceclofenac I.P. 100 mg
Thiocolchicoside I.P. 8 mg
Excipients q.s.
Approved Colour used
90. Tablets Aceclofenac and Thiocolchicoside Tablets Each film coated tablet contains : Self Approved -16.02.16
Aceclofenac I.P. 100 mg
Thiocolchicoside I.P. 4 mg
Excipients q.s.
Approved Colour used
91. Tablets Diacerein and Aceclofenac Tablets Each film coated tablet contains : Self Approved -16.02.16
Diacerein I.P. 50 mg
Aceclofenac I.P. 100 mg
Excipients q.s.
Approved Colour used
92. Tablets Gabapentin and Methylcobalamin Tablets Each film coated tablet contains : Self Approved -16.02.16
Gabapentin USP 300 mg
Methylcobalamin J.P. 500 mcg
Excipients q.s.
Approved Colour used
93. Tablets Paracetamol Tablets I.P. Each  uncoated tablet contains : Self Approved -16.02.16
Paracetamol I.P. 650 mg
Excipients q.s.
Approved Colour used
94. Tablets Aceclofenac and Paracetamol Tablets Each film coated tablet contains : Self Approved -16.02.16
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Excipients q.s.
Approved Colour used
95. Tablets Methylprednisolone Tablets I.P. Each  uncoated tablet contains : Self Approved -16.02.16
Methylprednisolone I.P. 4 mg
Excipients q.s.
Approved Colour used
96 Tablets Methylprednisolone Tablets I.P. Each  uncoated tablet contains : Self  Approved -16.02.16
Methylprednisolone I.P. 8 mg
Excipients q.s.
Approved Colour used
97. Tablets Methylprednisolone Tablets I.P. Each  uncoated tablet contains : Self  Approved -16.02.16
Methylprednisolone I.P. 16 mg
Excipients q.s.
Approved Colour used
98. Tablets Betamethasone Sodium Phosphate Tablets I.P. Each  uncoated tablet contains : Self  Approved -16.02.16
Betamethasone Sodium Phosphate

eq.to Betamethasone

I.P. 0.5 mg
Excipients q.s.
Approved Colour used
99. Tablets Paracetamol Tablets I.P. Each  uncoated tablet contains : Self Approved -16.02.16
Paracetamol I.P. 500 mg
Excipients q.s.
Approved Colour used
100 Tablets Esomeprazole  gastro-resistant Tablets I.P. Each  enteric coated tablet contains : Self Approved -16.02.16
Esomeprazole Magnesium Trihydrate

eq.to Esomeprazole

I.P. 20 mg
Excipients q.s.
Approved Colour used
101 Capsules Methylcobalamin, Alpha Lipoic Acid,Thiamine Mononitrate, Pyridoxine HCl and Folic Acid Capsules Each hard gelatin capsule contains Self Approved -20.02.16
Methylcobalamin J.P 1500 mcg
Alpha Lipoic Acid I.P. 100 mg
Thiamine Mononitrate I.P. 10 mg
Pyridoxine Hydrochloride I.P. 3 mg
Folic Acid I.P. 1.5 mg
Excipients q.s.
Appropriate overages of vitamins are added to compensate loss on storage
Approved colour used in empty capsule shells

 

 

 

 

 

 

 

 

 

102 Liquid Orals Milk of Magnesia, Liquid Paraffin and Sodium Picosulfate  oral emulsion Each 5ml (1 teaspoonful approx.)contains : Self Approved -20.02.16
Sodium Picosulfate B.P. 33.3 mg
Liquid Paraffin I.P. 1.25 ml
Milk of Magnesia I.P. 3.75 ml
Excipients q.s.
Indication: For symptomatic treatment of constipation in adults
Dosage: As directed by the physician
Approved Colour used
103 Capsules Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules Each hard gelatin capsule contains Self Approved -20.02.16
Methylcobalamin J.P 1000 mcg
Alpha Lipoic Acid I.P. 200 mg
Benfotiamine 100 mg
Folic Acid I.P. 1.5 mg
Pyridoxine HCl I.P. 3 mg
Inositol USP 100 mg
Excipients q.s.
Approved colour used in empty capsule shells
104 Tablets Methylprednisolone Tablets I.P. Each  film coated tablet contains : Self Approved-12.04.16
Methylprednisolone I.P. 4 mg
Excipients q.s.
Approved Colour used
105 Tablets Ranitidine Tablets I.P. Each  film coated tablet contains : Self  Approved-12.04.16
Ranitidine Hydrochloride

eq.to Ranitidine

I.P. 150 mg
Excipients q.s.
Approved Colour used
106 Tablets Serratiopeptidase Tablets I.P. Each  enteric coated tablet contains : Self Approved-12.04.16
Serratiopeptidase

(as enteric coated granules

eq.to enzymatic activity 20000 units)

I.P. 10 mg
Excipients q.s.
Approved Colour used
107 Liquid Orals Terbutaline Sulphate,Ambroxol hydrochloride, Guaiphenesin and Menthol Syrup Each 5ml contains: Self Approved-12.04.16
Terbutaline Sulphate I.P. 2.5 mg
Ambroxol hydrochloride I.P. 30 mg
Guaiphenesin I.P. 100 mg
Menthol I.P. 2.5 mg
Excipients q.s.
Flavoured syrupy base q.s.
Colour: Approved colour used
108 Liquid Orals Ambroxol hydrochloride, Levosalbutamol and Guaiphenesin Syrup Each 5ml contains: Self  Approved-12.04.16
Ambroxol hydrochloride I.P. 30 mg
Levosalbutamol 1 mg
Guaiphenesin I.P. 50 mg
Excipients q.s.
Flavoured syrupy base q.s.
Colour: Approved colour used
109 Liquid Orals Cyproheptadine Hydrochloride  and Tricholine Citrate Syrup Each 5ml contains : Self  Approved-26.04.16.
Cyproheptadine Hydrochloride I.P. 2 mg
Tricholine Citrate 275 mg
Excipients q.s.
Flavoured Syrupy base q.s.
Colour: Caramel I.P.
110 Liquid Orals Aceclofenac and Paracetamol Suspension Each 5ml contains : Self Approved-26.04.16.
Aceclofenac I.P. 50 mg
Paracetamol I.P. 125 mg
Excipients q.s.
Flavoured Syrupy base q.s.
Colour: Tartrazine
111 Liquid Orals Mefenamic Acid and Paracetamol Suspension Each 5ml contains : Self  Approved-26.04.16.
Mefenamic Acid I.P. 50 mg
Paracetamol I.P. 125 mg
Excipients q.s.
Flavoured Syrupy base q.s.
Colour: Sunset Yellow FCF
112 Liquid Orals Cyproheptadine Hydrochloride  and Tricholine Citrate Syrup Each 5ml contains : Self Approved-26.04.16.
Cyproheptadine Hydrochloride I.P. 2 mg
Tricholine Citrate 275 mg
Sorbitol Solution 70%

(Non-crystallizing)

I.P. 3.575 gm
Excipients q.s.
In a Palatable non syrupy base q.s.
Colour: Sunset Yellow FCF

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

113 Liquid Orals Tricholine Citrate Syrup Each 10ml contains : Self Approved-26.04.16.
Tricholine Citrate 0.55 gm
Sorbitol Solution 70%

(Non-crystallizing)

I.P. 7.150 gm
Excipients q.s.
In a Palatable non syrupy base q.s.
Colour: Approved colour used
114 Liquid Orals Diastase and Pepsin  syrup Each 5ml contains : Self Approved-26.04.16.
Diastase (1:1200) I.P. 50 mg
Pepsin (1:3000) I.P. 10 mg
Excipients q.s.
Flavoured Palatable base q.s.
Colour: Approved colour used
Dosage:

Adult: One teaspoonful immediately after the meal.

Childern: Half the adult dose.

As directed by the physician.

115 Liquid Orals Dicyclomine Hydrochloride and Activated Dimethicone Drops Each ml contains : Self Approved-26.04.16.
Dicyclomine Hydrochloride I.P. 10 mg
Activated Dimethicone I.P. 40 mg
Excipients q.s.
Flavoured Syrupy base q.s.
Colour: Sunset Yellow FCF
 For Paediatric use only
116 Liquid Orals Magaldrate and Simethicone Oral Suspension U.S.P. Each 5ml contains : Self  Approved-26.04.16.
Magaldrate (anhydrous) I.P. 500 mg
Simethicone I.P. 25 mg
Sorbitol Solution 70%

(Non-crystallizing)

I.P.
Excipients q.s.
Purified  Water I.P. q.s.
Colour: Sunset Yellow FCF
117 Liquid Orals Ibuprofen and Paracetamol Suspension Each 5ml contains : Self Approved-26.04.16.
Ibuprofen I.P. 100 mg
Paracetamol I.P. 125 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Colour: Sunset Yellow FCF
118 Tablets Aceclofenac Sustained Released Tablets 200mg Each film coated sustained released tablet contains : Self Approved-26.04.16.
Aceclofenac I.P. 200 mg
Excipients q.s.
Approved colour used
119 Tablets Drotaverine Hydrochloride and Mefenamic Acid Tablets Each film coated tablet contains : Self Approved-26.04.16.
Drotaverine Hydrochloride I.P. 80 mg
Mefenamic Acid I.P. 250 mg
Excipients q.s.
Approved colour used
120 Tablets Ciprofloxacin and Tindazole Tablets Each film coated tablet contains : Self  Approved-26.04.16.
Ciprofloxacin Hydrochloride

eq.to Ciprofloxacin

I.P. 500 mg
Tindazole I.P. 600 mg
Excipients q.s.
Approved Colour used
121 Tablets Trypsin,Bromelain and  Rustoside Trihydrate Tablets

 

Each enteric coated  tablet contains : Self Approved-26.04.16.
Trypsin B.P. 48 mg
Bromelain 90 mg
Rustoside Trihydrate B.P. 100 mg
Excipients q.s.
Colour: Yellow Oxide of Iron & Titanium Dioxide
122 Tablets Trypsin,Bromelain, Rustoside Trihydrate and Diclofenac Sodium Tablets

 

Each enteric coated  tablet contains : Self Approved-26.04.16.
Trypsin B.P. 48 mg
Bromelain 90 mg
Rustoside Trihydrate B.P. 100 mg
Diclofenac Sodium I.P. 50 mg
Excipients q.s.
Colour: Yellow Oxide of Iron & Titanium Dioxide

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

123 Tablets Diclofenac Sodium, Paracetamol and Chlorzoxazone  Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablet contains : Self Approved-26.04.16.
Diclofenac Sodium B.P. 50 mg
Paracetamol I.P. 325 mg
Chlorzoxazone USP 500 mg
Excipients q.s.
Approved Colour used
124 Tablets Aceclofenac,Paracetamol and Chlorzoxazone Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablet contains : Self Approved-26.04.16.
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Chlorzoxazone U.S.P. 250 mg
Excipients q.s.
Approved Colour used
125. Tablets Telmisartan  Tablets I.P. Each uncoated tablet contains : Self Approved-28.04.16.
Telmisartan I.P. 40 mg
Excipients q.s.
Approved colour used
126. Tablets Roxithromycin  Tablets I.P. Each film coated tablet contains : Self Approved-28.04.16.
Roxithromycin I.P. 150 mg
Excipients q.s.
Approved colour used
127. Capsules Tramadol Hydrochoride Capsules I.P. Each hard gelatin capsule contains : Self Approved-28.04.16.
Tramadol Hydrochoride I.P. 50 mg
Excipients q.s.
Approved colour used in empty capsule shells
128 Tablets Rabeprazole and Domperidone   Tablets Each enteric coated tablet contains : Self Approved-28.04.16.
Rabeprazole Sodium I.P. 20 mg
Domperidone I.P. 10 mg
Excipients q.s.
Approved colour used
129. Tablets Allopurinol Tablets  I.P. Each uncoated tablet contains : Self Approved-28.04.16.
Allopurinol I.P. 100 mg
Excipients q.s.
Approved colour used
130 Tablets Allopurinol Tablets  I.P. Each uncoated tablet contains : Self Approved-28.04.16..
Allopurinol I.P. 300 mg
Excipients q.s.
Approved colour used
131 Tablets Mefenamic Acid and Dicyclomine HCl Tablets Each uncoated tablet contains : Self Approved-28.04.16.
Mefenamic Acid I.P. 250 mg
Dicyclomine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved colour used
132. Tablets Diclofenac Potassium,  Paracetamol and Serratiopeptidase Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablet contains : Self Approved-28.04.16.
Diclofenac Potassium B.P. 50 mg
Paracetamol I.P. 325 mg
Serratiopeptidase

(eq.to enzymatic activity 20,000 units)

(as enteric coated granules)

I.P. 10 mg
Excipients q.s.
Approved Colour used
133. Tablets Aceclofenac,Paracetamol and Serratiopeptidase Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablet contains : Self Approved-28.04.16.

 

Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Serratiopeptidase

(eq.to enzymatic activity 30,000 units)

(as enteric coated granules)

I.P. 15 mg
Excipients q.s.
Approved Colour used
134 Liquid Orals Cyproheptadine Hydrochloride  and Tricholine Citrate Syrup Each 5ml contains : Self Approved-02.07.16.
Cyproheptadine Hydrochloride (anhydrous) I.P. 2 mg
Tricholine Citrate (65%) 275 mg
Sorbitol Solution 70% (Non-crystallizing) I.P.
Excipients q.s.
In a Flavoured Syrupy base q.s.
Colour: Caramel I.P.

 

135 Liquid Orals  Diastase and Pepsin  syrup Each 15ml contains : Self Approved-02.07.16.
Diastase (1:1200) I.P. 50 mg
Pepsin (1:3000) I.P. 10 mg
Excipients q.s.
Flavoured syrupy base q.s.
Colour: Approved colour used
136 Liquid Orals Diphenhydarmine HCl,Ammonium Chloride,Sodium Citrate and Menthol syrup Each 5ml (one teaspoonful) contains : Self Approved-02.07.16.
Diphenhydarmine  Hydrochloride I.P. 14.08 mg
Ammonium chloride I.P. 138.00 mg
Sodium Citrate I.P. 57.03 mg
Menthol I.P. 1.14 mg
Excipients q.s.
In a flavoured Syrupy base q.s.
Colour:Approved colour used
137 Liquid Orals Dextromethorphan Hydrobromide, Chlorpheniramine Maleate and Phenylepherine Hydrochloride Syrup Each 5ml (one teaspoonful) contains : Self Approved-02.07.16.
Dextromethrophan Hydrobromide I.P. 10 mg
Chlorpheniramine Maleate I.P. 2 mg
Phenylepherine Hydrochloride I.P. 5 mg
Excipients q.s.
In a flavoured syrup base q.s.
Colour: Ponceau-4R
Dosage:

Adults:10ml,3-4 time a day

Children:2-6 years 2.5ml,3-4 time a day  6-12 years 5ml,3-4 time a day

138 Liquid Orals Montelukast Sodium and Levocetirizine Dihydrochloride Syrup

 

(For Paediatric Use Only)

Each 5ml contains : Self Approved-02.07.16.
Montelukast Sodium

eq.to Montelukast

I.P. 4 mg
Levocetirizine Dihydrochloride I.P. 2.5 mg
Excipients q.s. mg
In a flavoured Syrupy base q.s.
Colour: Approved colour used
139 Tablets Calcium Carbonate and Vitamin D3 Tablets Each film coated tablet contains : Self Approved-02.07.16.
Calcium Carbonate

(from Oyster shells)

eq.to elemental Calcium

1250

 

500

mg

 

mg

Vitamin D3 I.P. 250 IU
Excipients q.s.
Approved colour used
140 Liquid Orals Vitamin D3 (Cholecalciferol) Drops I.P.

 

 

Each ml contains : Self Approved-02.07.16.
Vitamin D3 (Cholecalciferol) I.P. 800 IU
Excipients q.s. mg
In a flavoured Palatable base q.s.
Colour: Approved colour used
141 Tablets Calcium Citrate,Zinc,Vitamin D3 and Magnesium  Tablets Each uncoated tablet contains : Self Approved-02.07.16.
Calcium Citrate USP 1000 mg
Zinc Sulphate Monohydrate

eq.to elemental Zinc

I.P.  

4

 

mg

Vitamin D3 I.P. 200 IU
Magnesium Hydroxide

eq.to elemental Magnesium

I.P. 100 mg
Excipients q.s.
Approved colour used
142 Tablets Calcium Carbonate and Alfacalcidol Tablets Each film coated tablet contains : Self Approved-02.07.16.
Calcium Carbonate

(from Oyster shells)

eq.to elemental Calcium

1250

 

500

mg

 

mg

Alfacalcidol I.P. 0.25 mcg
Excipients q.s.
Approved colour used
143 Tablets Aceclofenac,Paracetamol and Serratiopeptidase Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablet contains : Self Approved-02.07.16.
Aceclofenac I.P. 100 mg
Paracetamol I.P. 325 mg
Serratiopeptidase

(eq.to enzymatic activity 20,000 units)

(as enteric coated granules)

I.P. 10 mg
Excipients q.s.
Approved Colour used

 

 

 

 

 

 

 

 

 

 

144 Tablets Betahistine Hydrochloride Tablets I.P. Each film coated tablet contains: Self Approved-02.07.16.
Betahistine Hydrochloride I.P. 8 mg
Excipients q.s.
Approved colour used
145 Tablets Ofloxacin Tablets I.P. Each film coated tablet contains: Self Approved-02.07.16.
Ofloxacin I.P. 400 mg
Excipients q.s.
Approved colour used
146 Tablets Febuxostat Tablets Each film coated tablet contains: Self Approved-02.07.16.
Febuxostat 40 mg
Excipients q.s.
Approved colour used
147 Capsules Clindamycin Capsule I.P. Each hard gelatin capsule contains: Self Approved-02.07.16.
Clindamycin Hydrochloride

eq.to Clindamycin

I.P. 300 mg
Excipients q.s.
Approved colour used empty capsule shells
148 Liquid Orals Lactulose Oral Solution U.S.P. Each 5ml contains: Self Approved-02.07.16.
Lactulose Conentrate

eq.to Lactulose

USP 3.35 gm
In a flavoured syrup base q.s.
Excipients q.s.
Approved colour used
149. Tablets Pregabalin (SR) and Methylcobalamin Tablets Each uncoated table contains: Self Approved-02.07.16.
Pregabalin (sustained released) I.P. 75 mg
Mecobalamin J.P. 1500 mcg
Excipients q.s.
Approved colour used
Appropriate overages of vitamin added to compensate loss on storage.
150. Liquid Orals Magaldrate and Simethicone Oral Suspension U.S.P. Each 5ml contains: Self Approved-02.07.16.
Magaldrate (anhydrous) I.P. 400 mg
Simethicone I.P. 20 mg
Sorbitol Solution 70% (Non-crystallizing) I.P.
Purified Water I.P. q.s.
Excipients q.s.
Approved Colour used
Dosage:

Adults and Children over 12 years: 1-2 teaspoonfuls between meals at bed time.

Children between 5-12 years: Half the dosage as above or as direct bt the physician.

 

151. Tablets Citicoline and Piracetam Tablets Each film coated tablet contains: Self Approved-02.07.16.
Citicoline Sodium

eq.to Citicoline

I.P. 500 mg
Piracetam I.P. 800 mg
Excipients q.s.
Approved colour used
152. Tablets Citicoline and Piracetam Tablets Each film coated tablet contains: Self Approved-02.07.16.
Citicoline Sodium

eq.to Citicoline

I.P. 500 mg
Piracetam I.P. 400 mg
Excipients q.s.
Approved colour used
153. Liquid Orals Terbutaline Sulphate,Bromhexine Hydrochloride, Guiaphenesin and Menthol Syrup Each 5ml (one teaspoonful) contains: Self Approved-02.07.16.
Terbutaline Sulphate I.P. 1.25 mg
Bromhexine Hydrochloride I.P. 4 mg
Guiaphenesin I.P. 50 mg
Menthol I.P. 1 mg
Excipients q.s.
In a Pleasantly flavoured syrupy base q.s.
Approved colour used
154. Liquid Orals Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Paracetamol Syrup Each 5ml contains: Self Approved-02.07.16.
Cetirizine Hydrochloride I.P. 2.5 mg
Phenylephrine Hydrochloride I.P. 5 mg
Paracetamol I.P. 125 mg
Excipients q.s.
In a  flavoured syrupy base q.s.
Approved colour used

 

 

155. Tablets Glimepride and Metformin

(Sustained Released) Tablets

Each uncoated tablet contains: Self Approved-02.07.16.
Glimpride I.P. 1 mg
Metformin (in sustained  release form) I.P. 500 mg
Excipients q.s.
Approved colour used
156. Tablets Voglibose Tablets I.P. Each uncoated tablet contains : Self Approved-02.07.16.
Voglibose I.P. 0.2 mg
Excipients q.s.
Approved colour used
157. Tablets Voglibose Tablets I.P. Each uncoated tablet contains : Self Approved-02.07.16.
Voglibose I.P. 0.3 mg
Excipients q.s.
Approved colour used
158. Liquid Orals Sucralfate and Oxetacaine Suspension Each 10ml contains : Self Approved-02.07.16.
Sucralfate USP 1 gm
Oxetacaine B.P. 20 mg
Excipients q.s.
In a  flavoured syrupy base q.s.
Approved colour used
Dosage:10ml.3 to times a day or directed by the physician
159. Liquid Orals Lycopene Enriched with Antioxidants, Multivitamin and Multimineral Syrup Each 10ml contains : Self Approved-02.07.16.
Lycopene 10% USP 2000 mcg
Niacinamide I.P. 25 mg
Folic Acid I.P. 100 mcg
Selenium Dioxide Monohydrate

eq.to Selenium

B.P. 35 mcg
Zinc (as Zinc Gluconate USP) 3 mg
Iodine (as Potassium Iodine IP) 100 mcg
Copper (as Cupric Sulphate USP) 500 mcg
Vitamin B12 I.P. 1 mcg
Vitamin B6 I.P. 1.5 mg
Excipients q.s.
In a  Pleasantly flavoured base q.s.
Appropriate overages of vitamins added to compensate for any loss on storage
Approved colour used
160. Tablets Terbinafine  Tablets USP Each uncoated tablet contains: Self Approved-16.07.16.
Terbinafine Hydrochloride

eq.to Terbinafine

 

USP 250 mg
Excipients q.s.
Approved colour used
161. Liquid Orals Calcium Carbonate and Vitamin D3 Syrup Each 5ml contains : Self Approved-16.07.16.
Calcium Carbonate

(Precipitate)

eq.to elemental Calcium

I.P.  

 

250

 

 

mg

Vitamin D3 I.P. 125 IU
Excipients q.s.
In a  flavoured syrupy base q.s.
Approved colour used
162. Liquid Orals Cyproheptadine Hydrochloride  and Tricholine Citrate Syrup

(For Veterinary Use Only)

Each 5ml contains : Self Approved-16.07.16.
Cyproheptadine Hydrochloride (anhydrous) I.P. 2 mg
Tricholine Citrate (65%) 275 mg
Sorbitol Solution 70% (Non-crystallizing) I.P.
Excipients q.s.
In a Flavoured Syrupy base q.s.
Colour: Caramel I.P.
163. Tablets Etizolam  Tablets Each film coated tablet contains : Self Approved-16.07.16.
Etizolam 0.50 mg
Excipients q.s.
Approved colour used
164 Capsules Itroconazole Capsules Each hard gelatin capsule contains : Self Approved-16.07.16.

 

 

 

 

 

 

 

Itroconazole Pellets

eq.to Itroconazole

B.P.  

100

 

mg

Excipients q.s.
Empty gelatin capsules contain
165. Capsules Itroconazole Capsules Each hard gelatin capsule contains : Self Approved-16.07.16.
Itroconazole Pellets

eq.to Itroconazole

B.P.  

200

 

mg

Excipients q.s.
Empty gelatin capsules contain
166. Liquid Orals Paracetamol, Cetirizine Hydrochloride, Phenylephrine Hydrochloride, Syrup Each 5ml contains : Self  

 

 

Approved-16.07.16.

 

 

 

 

 

 

 

 

 

Paracetamol I.P. 250 mg
Cetirizine Hydrochloride I.P. 2.5 mg
Phenylephrine Hydrochloride I.P. 2.5 mg
Menthol I.P. 1 mg
Excipients q.s.
In a  flavoured syrupy base q.s.
Approved colour used
167. Tablets Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine HCl and Caffeine (anhydrous) Tablets Each uncoated tablet contains : Self Approved-16.07.16.
Paracetamol I.P. 325 mg
Phenylephrine Hydrochloride I.P. 5 mg
Diphenhydramine Hydrochloride I.P. 25 mg
Caffeine (anhydrous) I.P. 30 mg
Excipients q.s.
Approved colour used
168. Tablets Cinnarizine  Tablets I.P. Each film coated tablet contains : Self Approved-16.07.16.

 

Cinnarizine I.P. 25 mg
Excipients q.s.
Approved colour used
169. Tablets Folic Acid  Tablets I.P. Each uncoated tablet contains : Self Approved-16.07.16.
Folic Acid I.P. 5 mg
Excipients q.s.
Approved colour used
170. Tablets Mecobalamin Tablets Each film coated tablet contains : Self Approved-16.07.16.
Mecobalamin J.P. 1500 mcg
Excipients q.s.
Approved colour used
171. Tablets Tranexamic Acid Tablets I.P. Each film coated tablet contains : Self Approved-16.07.16.
Tranexamic Acid I.P. 250 mg
Excipients q.s.
Approved colour used
172. Tablets Tranexamic Acid Tablets I.P. Each film coated tablet contains : Self Approved-16.07.16.
Tranexamic Acid I.P. 500 mg
Excipients q.s.
Approved colour used
173. Liquid Orals Sodium Picosulfate Oral Solution B.P. Each 5ml (1 teaspoonful approx.)contains : Self Approved-16.07.16.
Sodium Picosulfate B.P. 5 mg
Excipients q.s.
Dosage:As directed by the physician
Approved colour used
174. Tablets Etizolam  Tablets Each film coated tablet contains : Self Approved-16.07.16.
Etizolam 0.25 mg
Excipients q.s.
Approved colour used
175. Tablets Hydroxyzine Tablets I.P. Each uncoated tablet contains: Self Approved-10.08.16.
Hydroxyzine Hydrochloride I.P. 10 mg
Excipients q.s.
Approved colour used
176. Tablets Hydroxyzine Tablets I.P. Each uncoated tablet contains: Self Approved-10.08.16.
Hydroxyzine Hydrochloride I.P. 25 mg
Excipients q.s.
Approved colour used
177. Tablets Olopatadine Hydrochloride Tablets Each film coated tablet contains: Self Approved-10.08.16.
Olopatadine Hydrochloride USP 5 mg
Excipients q.s.
Approved colour used
178. Capsules Isotretinoin Capsules USP Each hard gelatin capsule contains: Self Approved-10.08.16.
Isotretinoin I.P. 20 mg
Excipients q.s.
Approved colour used in empty capsule shells

 

 

 

179. Capsules Isotretinoin Capsules USP Each hard gelatin capsule contains: Self Approved-10.08.16.
Isotretinoin I.P. 10 mg
Excipients q.s.
Approved colour used in empty capsule shells
180. Liquid Orals Pyridoxine Hydrochloride, Nicotinamide, Cyanocobalamin and Lysine Hydrochloride Syrup Each 10ml contains: Self Approved-10.08.16.
Pyridoxine Hydrochloride I.P. 0.75 mg
Nicotinamide I.P. 15 mg
Cyanocobalamin I.P. 2 mcg
Lysine Hydrochloride USP 375 mg
In a flavoured syrupy base q.s.
Excipients q.s.
Colour: Approved colour used
181. Liquid Orals Ambroxol Hydrochloride, Levocetirizine Hydrochloride, Guaiphenesin and Menthol Syrup Each 5ml contains: Self Approved-10.08.16.
Ambroxol Hydrochloride I.P. 15 mg
Levocetirizine Hydrochloride I.P. 2.5 mg
Guaiphenesin I.P. 50 mg
Menthol I.P. 1 mg
In a flavoured syrupy base q.s.
Excipients q.s.
Colour: Approved colour used
182. Tablets Glimepiride and Metformin Hydrochloride (SR)Tablets Each uncoated tablet contains: Self Approved-10.08.16.
Glimepiride I.P. 2 mg
Metformin Hydrochloride (sustained released) I.P. 500 mg
Excipients q.s.
Approved colour used
183. Tablets Glimepiride and Metformin Hydrochloride (SR)Tablets Each uncoated tablet contains: Self Approved-10.08.16.
Glimepiride I.P. 2 mg
Metformin Hydrochloride (sustained released) I.P. 1000 mg
Excipients q.s.
Approved colour used
184. Tablets Olmesartan Medoxomil and Hydrochlorothiazide Tablets Each uncoated tablet contains: Self Approved-10.08.16.
Olmesartan Medoxomil I.P. 40 mg
Hydrochlorothiazide I.P. 25 mg
Excipients q.s.
Approved colour used
185. Tablets Voglibose and Metformin Hydrochloride Tablets Each film coated tablet contains : Self Approved-10.08.16.
Voglibose I.P. 0.2 mg
Metformin Hydrochloride I.P. 500 mg
Excipients q.s.
Approved colour used
186. Tablets Voglibose and Metformin Hydrochloride (SR) Tablets Each film coated tablet contains : Self Approved-10.08.16.
Voglibose I.P. 0.3 mg
Metformin Hydrochloride

(sustained Released)

I.P. 500 mg
Excipients q.s.
Approved colour used
187. Tablets Amlodipine Besilate  and Atenolol Tablets Each uncoated tablet contains: Self Approved-10.08.16.
Amlodipine Besilate

eq.to Amlodipine

I.P. 5 mg
Atenolol I.P. 50 mg
Excipients q.s.
Approved colour used
188. Tablets Citicoline Tablets Each film coated tablet contains: Self Approved-10.08.16.
Citicoline Sodium

eq.to Citicoline

I.P. 500 mg
Excipients q.s.
Approved colour used
189. Tablets Losartan Potassium  and    Hydrochlorothiazide Tablets I.P. Each film coated tablet contains: Self Approved-10.08.16.
Losartan Potassium I.P. 50 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved colour used
190. Tablets Loratadine Tablets  USP Each uncoated tablet contains: Self Approved-10.08.16.

 

Loratadine USP 10 mg
Excipients q.s.
Approved colour used

 

 

 

 

191 Tablets Rosuvastatin Calcium Tablets I.P. Each film coated tablet contains: Self  Approved-27.10.16.

 

Rosuvastatin Calcium

eq.to Rosuvastatin

I.P. 5 mg
Excipients q.s.
Approved Colour used

 

192 Tablets Rosuvastatin Calcium Tablets I.P. Each film coated tablet contains: Self  Approved-27.10.16.

 

Rosuvastatin Calcium

eq.to Rosuvastatin

I.P. 10 mg
Excipients q.s.
Approved Colour used

 

193 Tablets Telmisartan and Hydrochlorothiazide Tablets U.S.P. Each film coated tablet contains: Self Approved-27.10.16.

 

Telmisartan I.P. 40 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used

 

194 Tablets Telmisartan and Hydrochlorothiazide Tablets U.S.P. Each film coated tablet contains: Self Approved-27.10.16.

 

Telmisartan I.P. 80 mg
Hydrochlorothiazide I.P. 12.5 mg
Excipients q.s.
Approved Colour used

 

195 Tablets Metformin Hydrochloride Sustained Released Tablets I.P. Each uncoated tablet contains: Self Approved-27.10.16.

 

Metformin Hydrochloride

(sustained released)

I.P. 500 mg
Excipients q.s.
Approved Colour used

 

196 Tablets Duloxetine Hydrochloride Tablets Each film coated tablet contains: Self Approved-27.10.16.

 

Duloxetine Hydrochloride

eq.to Duloxetine

USP 30 mg
Excipients q.s.
Approved Colour used

 

197 Tablets Amlodipine Besilate  Tablets I.P. Each film coated tablet contains: Self Approved-27.10.16.

 

Amlodipine Besilate

eq.to Amlodipine

I.P. 5 mg
Excipients q.s.
Approved Colour used

 

198 Capsules Esomperazole (EC)  and Itopride (SR) Hydrochloride Capsules Each hard gelatin capsule contains: Self Approved-27.10.16.

 

Esomperazole Magnesium Trihydrate

eq.to Esomperazole

(as enteric coated pellets)

I.P.  

40

 

mg

Itopride Hydrochloride

(as sustained released pellets)

150 mg
Excipients q.s.
Approved colour used in empty capsule shells

 

199 Liquid Orals Paracetamol, Cetirizine Hydrochloride, Phenylephrine Hydrochloride and Menthol Suspension Each 5ml contains : Self Approved-27.10.16.

 

Paracetamol I.P. 250 mg
Cetirizine Hydrochloride I.P. 2.5 mg
Phenylephrine Hydrochloride I.P. 2.5 mg
Menthol I.P. 1 mg
Excipients q.s.
In a  flavoured syrupy base q.s.
Approved colour used
200 Tablets Levosulpride Tablets Each film coated tablet contains: Self Approved-27.10.16.

 

Levosulpride 50 mg
Excipients q.s.
Approved Colour used
201 Tablets Dexthromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Each 5ml contains: Self Approved-27.10.16.

 

Dexthromethorphan Hydrobromide I.P. 10 mg
Chlorpheniramine Maleate I.P. 2 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used

 

 

 

 

 

202 Tablets Diclofenac  Potassium and  Serratiopeptidase Tablets Each enteric coated tablet contains: Self Approved-27.10.16.

 

Diclofenac  Potassium B.P. 50 mg
Serratiopeptidase

(eq.to enzymatic activity 20,000units)

I.P. 10 mg
Excipients q.s.
Approved Colour used

 

203 Tablets Escitalopram Tablets I.P. Each film coated tablet contains: Self Approved-03.12.16.

 

Escitalopram Oxalate

eq.to Escitalopram

I.P. 5 mg
Excipients q.s.
Approved Colour used

 

204 Tablets Escitalopram Tablets I.P. Each film coated tablet contains: Self Approved-03.12.16.

 

Escitalopram Oxalate

eq.to Escitalopram

I.P. 10 mg
Excipients q.s.
Approved Colour used

 

205 Tablets Eperisone Hydrochloride Tablets Each film coated tablet contains: Self Approved-03.12.16.

 

Eperisone Hydrochloride 50 mg
Excipients q.s.
Approved Colour used

 

206 Tablets Eperisone Hydrochloride and Paracetamol Tablets Each film coated tablet contains: Self Approved-03.12.16.

 

Eperisone Hydrochloride 50 mg
Paracetamol I.P. 325 mg
Excipients
Approved Colour used

 

207 Tablets Linezolid Tablets I.P. Each film coated tablet contains: Self Approved-03.12.16.

 

Linezolid I.P. 600 mg
Excipients q.s.
Approved Colour used

 

208 Tablets Folic Acid Tablets I.P. Each film coated tablet contains: Self Approved-03.12.16.

 

Folic Acid I.P. 10 mg
Excipients q.s.
Approved Colour used

 

209 Tablets Diclofenac Potassium Paracetamol and Chlorzoxazone Tablets

(Warning: Overdose of this drug has potential of severe liver injury & allergic reactions (e.g. swelling of face, mouth & throat, difficulty in breathing, itching or rashes)

Each film coated tablets contains : Self Approved-03.12.16.

 

Diclofenac Potassium B.P. 50 mg
Paracetamol I.P. 325 mg
Chlorzoxazone USP 250 mg
Excipients q.s.
Approved colour used

 

210 Liquid Orals Montelukast Sodium and Levocetirizine Dihydrochloride Suspension

 

(For Paediatric Use Only)

Each 5ml contains : Self Approved-03.12.16.

 

Montelukast Sodium

eq.to Montelukast

I.P. 4 mg
Levocetirizine Dihydrochloride I.P. 2.5 mg
Excipients q.s. mg
In a flavoured Syrupy base q.s.
Colour: Approved colour used

 

 

211 Capsules Rabeprazole Sodium(EC) and Aceclofenac(SR) Capsules Each hard gelatin capsule contains: Self Approved-03.12.16.

 

Rabeprazole Sodium

(as enteric coated pellets)

I.P. 20 mg
Aceclofenac

(as sustained release pellets)

I.P. 200 mg
Excipients q.s.
Approved Colour used in empty capsule shells

 

212 Tablets Paracetamol, Phenylephrine Hydrochloride, Diphenhydramine HCl and Caffeine (anhydrous) Tablets Each uncoated tablet contains : Self Approved-03.12.16.

 

Paracetamol I.P. 325 mg
Phenylephrine Hydrochloride I.P. 5 mg
Diphenhydramine Hydrochloride I.P. 25 mg
Caffeine (anhydrous) I.P. 30 mg
Excipients q.s.
Approved colour used

 

 

 

 

213 Liquid Orals Ofloxacin, Metronidazole Benzoate and Simethicone Suspension

(For Paediatric Use)

Each 5ml contains: Self  Approved-03.12.16.

 

Ofloxacin I.P. 50 mg
Metronidazole Benzoate

eq.to Metronidazole

I.P. 120 mg
Simethicone I.P. 10 mg
Excipients q.s.
In a flavoured syrupy base q.s.
Approved Colour used

 

214

 

Tablets Paracetamol, Cetirizine Hydrochloride & Phenylephrine Hydrochloride Tablets Each film coated tablet contains: Self Approved-03.12.16.

 

Paracetamol  I.P. 325 mg
Cetirizine Hydrochloride  I.P. 5 mg
Phenylephrine Hydrochloride  I.P. 10 mg
Excipients q.s.
Approved Colour used